Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
para-Sulfonatocalixarene and polyamidoamine dendrimer nanocomplexes as delivery vehicles for a novel platinum anticancer drug
- At: 2017 FIP Congress in Stockholm (Sweden)
- Type: Poster
- By: MITRA, Sayan (The University of Sydney, Faculty of Pharmacy, Sydney, Australia)
- Co-author(s): Chi Ting Pang: Faculty of Pharmacy, The University of Sydney, Sydney, Australia
Sayan Mitra: Faculty of Pharmacy, The University of Sydney, Sydney, Australia
Alaina Ammit: Woolcock Emphysema Research Centre, Woolcock Institute of Medical Research, Sydney, Australia
Yu Qing Elysia Ong: Faculty of Pharmacy, The University of Sydney, Sydney, Australia
Nial Wheate: Faculty of Pharmacy, The University of Sydney, Sydney, Australia
BackgroundsPlatinum-based drugs, like cisplatin, play a central role in nearly half of all anticancer treatments. Despite their success, these drugs have two major limitations; severe side effects and the ability of cancers to develop drug resistance. As a result, new methods of targeting platinum drugs to cancers are needed.
AimsInvestigate para-s.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019